TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

Pfizer and Moderna ramp up EU Covid vaccine prices

4 点作者 hheikinh将近 4 年前

4 条评论

MikeUt将近 4 年前
&quot;At least 97% of the funding for the development of the Oxford&#x2F;AstraZeneca Covid-19 vaccine has been identified as coming from taxpayers or charitable trusts [..] Oxford University initially said any vaccine it developed would be open to qualified manufacturers to produce without paying royalties, and priced either at cost or at a small profit. However, by August 2020, reportedly at the urging of the Bill &amp; Melinda Gates Foundation, among others, the university decided to change course. It entered an exclusive licensing agreement with the British-Swedish drugmaker AstraZeneca.&quot; - <a href="https:&#x2F;&#x2F;www.theguardian.com&#x2F;science&#x2F;2021&#x2F;apr&#x2F;15&#x2F;oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded" rel="nofollow">https:&#x2F;&#x2F;www.theguardian.com&#x2F;science&#x2F;2021&#x2F;apr&#x2F;15&#x2F;oxfordastraz...</a><p>I&#x27;d like to see a similar analysis made for the Pfizer and Moderna vaccines.
tomohawk将近 4 年前
Given how the EU treated AstraZeneca, it makes sense that other companies would price in the expected risk of doing business with the EU.
sorethescore将近 4 年前
Read the room, Pfizer and Moderna, this move will backfire in a big way if they go through with it.
simonblack将近 4 年前
It&#x27;s called &#x27;A captive market&#x27;.